πŸ‡ΊπŸ‡Έ FDA
Patent

US 8067202

Bacterial superantigen vaccines

granted A61PA61P31/04

Quick answer

US patent 8067202 (Bacterial superantigen vaccines) held by The United States of America as represented by the Secretary of the Army expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61P, A61P31/04